AMGN.NASDAQAmgen INC

Form 4: Amgen SVP & CCO Nancy Grygiel Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4

📋All filings for Amgen INC
🔒Login to Follow

Nancy Grygiel, SVP & CCO of Amgen, reports a transaction involving common stock and holdings in the company's 401(k) plan.

Summary

  • Nancy Grygiel, SVP & CCO of Amgen, filed a Form 4 detailing changes in her beneficial ownership of Amgen stock.
  • On May 5, 2024, Grygiel disposed of 82 shares of common stock at a price of $311.29.
  • Following the reported transaction, Grygiel directly owns 9,801 shares of Amgen common stock.
  • This includes Restricted Stock Units (RSUs) that will vest on various dates in the future.
  • Grygiel also indirectly owns 99.9653 shares through the company's 401(k) plan.
  • These shares represent interests in the company's stock fund as of the filing date.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions by a company executive. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates the transactions of a high ranking officer at Amgen.

Key Dates

DateDescription
05/05/2024Date of transaction involving common stock.
05/06/2024Date of Form 4 filing.
07/31/2024Vesting date for 2,780 RSUs.
04/30/2025Vesting date for 199 RSUs.
05/02/2025Vesting date for installments of 435 and 635 RSUs.
05/02/2026Vesting date for installments of 435 and 635 RSUs.
05/02/2027Vesting date for installments of 635 RSUs.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.